Health Alert for Lake Lorraine-West in Deltona
Christmas Crazy Cart Parade in New Smyrna Beach

Monoclonal Antibody Treatment Locations in Volusia County

Volusia

The State of Florida successfully deployed and expanded state-run, lifesaving monoclonal antibody therapy treatment sites statewide. Throughout this process, the State has worked with a robust network of community partners to ensure the health care sector is equipped to administer monoclonal antibody therapy treatment to Floridians.

To support this transition of monoclonal antibody therapy treatment administration to locally operated providers, the state-supported monoclonal antibody therapy treatment site at Ormond Beach Senior Center, 351 Andrews Street in Volusia County, will close on November 5, 2021.

Alternative monoclonal antibody therapy treatment locations in this area are listed below:

AdventHealth Daytona Beach

301 Memorial Medical Parkway

Daytona Beach, Florida

 

AdventHealth Deland

701 W. Plymouth Ave

Deland, Florida

 

Halifax Health Medical Center

303 N. Clyde Morris Blvd

Daytona Beach, Florida

 

AdventHealth New Smyrna Beach

401 Palmetto St

New Smyrna Beach, Florida

 

AdventHealth Fish Memorial

1055 Saxon Blvd

Orange City, Florida

 

Halifax Health /UF Health Medical Center of Deltona

3300 Halifax Crossings Blvd

Deltona, Florida

 

Family Health Source

2160 Howland Blvd #110

Deltona, Florida

 

The Florida Department of Health will continue to allocate doses of monoclonal antibodies to health care providers with high utilization rates and will ensure inventory levels meet county demand.

Monoclonal Antibody Therapy Treatment Locator:

Monoclonal antibody therapy treatment locations can be found at FloridaHealthCOVID19.gov and by using the National Infusion Center Association’s treatment locator.

Benefits of Treatment:

Monoclonal antibodies help the immune system recognize and respond effectively to the COVID-19 virus.

Monoclonal antibody therapy treatment is for individuals who have contracted or been exposed to COVID-19. Monoclonal antibody therapy treatment can prevent severe illness, hospitalization, and death in high-risk patients who have contracted COVID-19. Specifically, it:

  • Reduces the risk of death/hospitalization by 70%-85%.

Reduces the risk of developing symptomatic disease by over 80%.

Information posted 11/5/2021

Read site compensation and affiliate link disclosure.


Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

The comments to this entry are closed.